Sherlock Biosciences
Top Five Articles on 360Dx Last Week: Sepsis Testing in 2024; Clinical Labs and FDA LDT Rule; More
Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
Both firms will develop rapid, home-use diagnostic tests to simultaneously detect SARS-CoV-2, influenza A, and influenza B.
Gates Foundation Awards Multiple Grants for Omics, Dx Projects in August
Awardees include Quantigen, Sherlock Biosciences, the Netherlands National Institute for Public Health and the Environment, Stanford University, and Rutgers University.
In Brief This Week: Thermo Fisher Scientific; Quest, Danaher; and More
News items for the week of Aug. 14, 2023.
The firm has a handful of beta users of the assay design tool but has not previously publicly disclosed its strategy to make the method broadly available.